Community support may improve chances of African-American smokers quitting
-->
Trusting neighbors and community may aid smoking cessation in African-American smokers, accordingly to a study published in the Annals of Behavioral Medicine, a publication of the Society of Behavioral Medicine.
MD Anderson researchers collected data from 397 African-Americans seeking...
Three new therapies increase options for CML and some ALL patients
Patients with chronic myeloid leukemia (CML) or acute lymphoblastic leukemia that carries the Philadelphia chromosome (Ph+ALL) who can't tolerate...
Three new therapies increase options for CML patients
Path-breaking targeted therapies have extended the lives of people with chronic myeloid leukemia (CML) or acute lymphoblastic leukemia that...
Melanoma faculty contribute to Nature Medicine's 2012 top advances
By Leslie Loddeke, Publications Coordinator, Melanoma Medical Oncology Department
MD Anderson Melanoma Medical Oncology Chair Patrick Hwu, M.D., and Professor Wen-Jen Hwu, M.D., Ph.D., were coauthors of one of the papers named in Nature Medicine's "Notable advances 2012" list of the year's top basic biomedical discoveries.
The article notes "certain areas of biomedicine saw fast-paced...
Ibrutinib is best 'single-agent ever tested in mantle cell lymphoma'
An international study of ibrutinib in people with relapsed or refractory mantle cell lymphoma (MCL) continues to show unprecedented and durable...
Umbilical cord blood stem cells build new blood supply faster after lab expansion
-->
A new technique for expanding blood stem cells from umbilical cords in the lab before transplanting them into a patient reduces...
Clinical trials show benefit for lymphoma patients @ASH
A drug approved for treating resistant versions of two types of lymphoma knocked down the disease in all 26 patients evaluated in a phase...
Day two @ASH: Phase 2 clinical trial results for new CML drug, FDA okays it today
Updated: 4:30 p.m. Friday, Dec. 14
The U.S. Food and Drug Administration approved ponatinib (Iclusig) for chronic myeloid leukemia...
Day one: MD Anderson @ American Society of Hematology
Elnar Koseoglu of Physician Relations and Bradley Swinney of Banner MD Anderson await the afternoon rush at booth 3500 in the exhibition hall...
MD Anderson physician receives award for decades of accomplishments
Fifty years from now when an author is compiling a review of modern cancer therapy for a historical publication, he'll undoubtedly recognize...
MD Anderson research makes ASCO Clinical Cancer Advances for 2012
Two papers published by MD Anderson clinical researchers are included in the American Society of Clinical Oncology's report, Clinical Cancer...